…. Receives Commendation at the International Pharmaceutical Regulators Programme in Prague
By Bassey Asuquo
FLOWERBUDNEWS: The National Agency for Food and Drug Administration and Control (NAFDAC), has recorded significant milestones in regulatory system strengthening, digital innovation, pharmaceutical manufacturing, enforcement and international collaboration in 2026.
These achievements were highlighted during the Agency’s Regulatory Update presentation at a just concluded conference, a statement by Sayo Akintola NAFDAC Resident Media Consultant, disclosed.
A major highlight is NAFDAC’s sustained WHO Maturity Level 3 status and ongoing transition towards Maturity Level 4, the highest level of the WHO Global Benchmarking Tool.
Key digital initiatives supporting this ambition include the Integrated Regulatory Information Management System (IRIMS), Performance Management System (i-PMS), the GMP Inspection (GMPi), Application and AI-assisted Technical Screening Tools (TST), and the Revised Med Safety App to Strengthen Reporting of Substandard and Falsified Medical Products and Adverse Drug Reactions in Nigeria.
The Agency recorded remarkable enforcement achievements between January and August 2026, including 5,542 enforcement activities, 213 raids, 821 product seizures, 179 premises closed, 52 arrests and 221 sanctions.
It also destroyed unwholesome products valued at approximately ₦22.73 billion through 22 destruction exercises.
NAFDAC also recorded significant progress in promoting local pharmaceutical manufacturing through its 5+5 Policy, with over 70 per cent of finished pharmaceutical products under the policy and Ceiling 36 products now locally manufactured.
This initiative is aimed at reducing import dependence and strengthening Nigeria’s medicine security.
NAFDAC’s growing influence in Africa is further demonstrated by its emergence as a reference National Regulatory Authority, hosting regulatory authorities from Uganda, The Gambia, Mozambique and Côte d’Ivoire for technical capacity building and institutional benchmarking.
Nigeria also ratified the African Medicines Agency (AMA) Treaty and deposited its instruments of ratification on October 25, 2026.
These milestones reflect the strategic vision and purposeful leadership of the Director-General, Prof. Mojisola Christianah Adeyeye, whose administration continues to drive institutional transformation, science-based regulation, digital innovation and international regulatory cooperation.
NAFDAC continues to strengthen its regulatory capacity, enhance public health protection and position Nigeria as a leading regulatory authority in Africa. (FLOWERBUDNEWS)





